“Analyzing the AI scores of screened individuals over time could provide insight into how early detectable changes arise, potentially allowing for earlier intervention," researchers write in Radiology.

Experts say these findings could offer radiology providers the opportunity to intervene before cardiovascular conditions worsen.

AI shines as a first reader for ruling out suspicious findings in breast cancer screening exams, a new analysis in Radiology: Artificial Intelligence reveals.

The study, which was managed by the American College of Radiology, is raising important questions related to the benefits of GLP-1 use.

Researchers are hopeful that the patch can give providers the data needed to identify critical abnormalities earlier. 

The needles were added to the FDA’s list of device shortages in April months after a major manufacturer stopped shipments to “correct an issue."

And the uptick in incidence rates is not exclusive to any one demographic or tumor subtype, experts caution.

The TowerBrook Capital-backed breast imaging provider announced the latest openings on May 11, with new centers in Houston and Doylestown, Pennsylvania.